Highlights
NASDAQ: KZIA       Kazia Therapeutics Ltd
Last Price Today's Change   Day's Range   Trading Volume
10.045   -0.115 (1.13%)  9.63 - 10.25  28,354

Overview

 
Avg Volume (4 weeks):85,829
4 Weeks Range:8.48 - 10.462
4 Weeks Price Volatility (%):
78.96%
52 Weeks Range:2.47 - 15.85
52 Weeks Price Volatility (%):
56.61%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The company has three technologies – PI3K inhibitors, superbenzopyran, and anti-tropomyosin. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; Trilexium, has a potential application across a range of different cancer types.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2886  3452  311  3256 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 OBLN 5.82+4.21 
 LK 1.38+1.38 
 AMC 3.00-0.06 
 ADMP 1.439+0.634 
 SNDL 0.696+0.006 
 WPX 9.43+0.48 
 CTRM 0.326-0.015 
 CLBS 3.40+1.77 
 BNGO 8.019-1.121 
 BB 13.06+0.71